Nothing Special   »   [go: up one dir, main page]

FR2333515B1 - - Google Patents

Info

Publication number
FR2333515B1
FR2333515B1 FR7636173A FR7636173A FR2333515B1 FR 2333515 B1 FR2333515 B1 FR 2333515B1 FR 7636173 A FR7636173 A FR 7636173A FR 7636173 A FR7636173 A FR 7636173A FR 2333515 B1 FR2333515 B1 FR 2333515B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7636173A
Other versions
FR2333515A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19752553963 external-priority patent/DE2553963A1/de
Priority claimed from DE19752553964 external-priority patent/DE2553964A1/de
Priority claimed from DE19752553962 external-priority patent/DE2553962A1/de
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of FR2333515A1 publication Critical patent/FR2333515A1/fr
Application granted granted Critical
Publication of FR2333515B1 publication Critical patent/FR2333515B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7636173A 1975-12-01 1976-12-01 Compositions pharmaceutiques pour le traitement des troubles du metabolisme du calcium Granted FR2333515A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19752553963 DE2553963A1 (de) 1975-12-01 1975-12-01 Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels
DE19752553964 DE2553964A1 (de) 1975-12-01 1975-12-01 Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels
DE19752553962 DE2553962A1 (de) 1975-12-01 1975-12-01 Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels

Publications (2)

Publication Number Publication Date
FR2333515A1 FR2333515A1 (fr) 1977-07-01
FR2333515B1 true FR2333515B1 (fr) 1980-03-07

Family

ID=27186643

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7636173A Granted FR2333515A1 (fr) 1975-12-01 1976-12-01 Compositions pharmaceutiques pour le traitement des troubles du metabolisme du calcium

Country Status (7)

Country Link
US (1) US4086334A (fr)
AT (1) AT347578B (fr)
DK (1) DK506476A (fr)
FR (1) FR2333515A1 (fr)
GB (1) GB1571279A (fr)
NL (1) NL7612673A (fr)
SE (1) SE7612534L (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2432869A1 (fr) * 1978-08-08 1980-03-07 Armour Montagu Laboratoire Compositions pour le traitement de l'osteoporose associant la calcitonine et le phosphore
US4663309A (en) * 1983-06-29 1987-05-05 University Patents, Inc. Novel peptide hormones with calcitonin-like activity
US4514331A (en) * 1983-06-29 1985-04-30 University Patents, Inc. Peptide hormones with calcitonin-like activity
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
US5104863A (en) * 1984-12-21 1992-04-14 The Procter & Gamble Company Certain bicycloalkane and azabicycloalkane-1,1-diphosphonic acid derivatives useful for treating diseases associated with abnormal calcium and phosphate metabolism
US4687768A (en) * 1984-12-21 1987-08-18 The Procter & Gamble Company Certain hexahydroindan-2,2-diphosphonic acids useful in treating diseases associated with abnormal calcium and phosphate metabolism
JPS62185092A (ja) * 1986-02-07 1987-08-13 Teijin Ltd 新規ホスホン酸誘導体および除草剤
NL8701143A (nl) * 1986-05-27 1987-12-16 Sandoz Ag Farmaceutische preparaten.
US4868164A (en) * 1986-12-19 1989-09-19 Norwich Eaton Pharmaceuticals, Inc. Octahydro-pyridine diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
MX21452A (es) * 1989-07-07 1994-01-31 Ciba Geigy Ag Preparaciones farmaceuticas que se administran en forma topica.
US5139786A (en) * 1989-07-07 1992-08-18 Ciba-Geigy Corporation Topical formulations
DE3930130A1 (de) * 1989-09-09 1991-03-21 Boehringer Mannheim Gmbh Neue amidingruppen-haltige diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US5760021A (en) * 1992-05-29 1998-06-02 The Procter & Gamble Company Phosphonocarboxylate compounds pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
DE69634487T2 (de) * 1995-09-29 2006-01-05 Novartis Ag Verfahren zur behandlung navikularer krankheiten bei pferden
US5753633A (en) * 1997-04-11 1998-05-19 Colgate-Palmolive Company Method of inhibiting bone resorption
EP1671638A1 (fr) * 2000-09-18 2006-06-21 F H Faulding & Co. Limited Solutions de diphosphonates
DE10217314A1 (de) * 2002-04-18 2003-11-13 Fumapharm Ag Muri Carbocyclische und Oxacarboncyclische Fumarsäure-Oligomere
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
RU2313339C2 (ru) * 2003-09-09 2007-12-27 Фумафарм Аг Применение производных фумаровой кислоты для лечения сердечной недостаточности и астмы

Also Published As

Publication number Publication date
FR2333515A1 (fr) 1977-07-01
DK506476A (da) 1977-06-02
NL7612673A (nl) 1977-06-03
US4086334A (en) 1978-04-25
GB1571279A (en) 1980-07-09
SE7612534L (sv) 1977-06-02
AT347578B (de) 1979-01-10
ATA885676A (de) 1978-05-15

Similar Documents

Publication Publication Date Title
CH604605A5 (fr)
CH599366A5 (fr)
BG22285A1 (fr)
BG23334A1 (fr)
CH279875A4 (fr)
CH581501A5 (fr)
CH586806A5 (fr)
CH588603A5 (fr)
CH588628A5 (fr)
CH588672A5 (fr)
CH588718A5 (fr)
CH589171B5 (fr)
CH592193A5 (fr)
CH592204A5 (fr)
CH592311A5 (fr)
CH593377A5 (fr)
CH594093A5 (fr)
CH595810A5 (fr)
CH595912A5 (fr)
CH603743A5 (fr)
CH597775A5 (fr)
CH597942A5 (fr)
CH598496A5 (fr)
CH598520A5 (fr)
CH599041A5 (fr)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse